Torren Management »

Atrium Therapeutics shares owned by Torren Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Torren Management from 13F filings

Historical chart of Torren Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Torren Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Torren Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $53 4 13.25

More positions owned by Torren Management

Avantis Total Equity Markets Etf Etf (AVTM)
Avantis U.S. Equity ETF Etf (AVUS)
Avantis International Equity ETF Etf (AVDE)
Dimensional Short-Duration Fixed Income ETF Etf (DFSD)
Avantis U.S. Quality ETF Etf (AVUQ)
Dimensional Core Fixed Income ETF Etf (DFCF)
Avantis Emerging Markets Equity ETF Etf (AVEM)
Avantis U.S. Small Cap Value ETF Etf (AVUV)
Dimensional Global ex US Core Fixed Income ETF Etf (DFGX)
Dimensional Ultrashort Fixed Income ETF Etf (DUSB)
Dimensional US High Profitability ETF Etf (DUHP)
Dimensional International Core Equity 2 ETF Etf (DFIC)
PIMCO 15 Year U.S. TIPS Index ETF Etf (LTPZ)
Dimensional US Core Equity 2 ETF Etf (DFAC)
Dimensional International High Profitability ETF Etf (DIHP)

View all positions for Torren Management

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics